Method of diagnosing and treating cancer using B-catenin splice variants
US10000813B2 · kind B2 · utility
0Cited by
3References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 3, 2012 |
| Grant date | Jun 19, 2018 |
| Priority date | — |
| Expiry date | Oct 30, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/136
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to method and compositions for treating and diagnosing cancer, in particular β-catenin related cancers. In general, the methods include administering RNAi constructs. The invention further relates to methods of identifying CTNNB1 related cancer therapeutics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.